Literature DB >> 17456799

Sirtuin functions in health and disease.

Hiroyasu Yamamoto1, Kristina Schoonjans, Johan Auwerx.   

Abstract

Sirtuins or Sir2 (silent information regulator 2)-related enzymes have originally been defined as a family of nicotinamide adenine dinucleotide-dependent enzymes that deacetylate lysine residue on various proteins. Certain sirtuins have in addition an ADP-ribosyltransferase activity. The sirtuins are remarkably conserved throughout evolution from archaebacteria to eukaryotes. The mammalian sirtuins SIRT1-SIRT7 are implicated in a variety of cellular functions ranging from gene silencing, over the control of the cell cycle and apoptosis, to energy homeostasis. On a whole-body level, the wide range of cellular activities of the sirtuins suggests that they could constitute therapeutic targets to combat metabolic, neurodegenerative, and proliferative diseases. Here, we review some of the recent data related to the sirtuins and discuss their mode of action, their biological role in cellular and organismal models, and their possible association to age-related human diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456799     DOI: 10.1210/me.2007-0079

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  157 in total

Review 1.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

2.  HDAC3 is negatively regulated by the nuclear protein DBC1.

Authors:  Claudia C S Chini; Carlos Escande; Veronica Nin; Eduardo N Chini
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

3.  Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE study.

Authors:  Erwin Reiling; Jana V van Vliet-Ostaptchouk; Esther van 't Riet; Timon W van Haeften; Pascal A Arp; Torben Hansen; Dennis Kremer; Marlous J Groenewoud; Els C van Hove; Johannes A Romijn; Jan W A Smit; Giel Nijpels; Robert J Heine; André G Uitterlinden; Oluf Pedersen; P Eline Slagboom; Johannes A Maassen; Marten H Hofker; Leen M 't Hart; Jacqueline M Dekker
Journal:  Eur J Hum Genet       Date:  2009-02-11       Impact factor: 4.246

4.  The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes.

Authors:  Ben Buelow; Yumei Song; Andrew M Scharenberg
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

5.  SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.

Authors:  Jenna D Lovaas; Lijia Zhu; Christine Y Chiao; Vanessa Byles; Douglas V Faller; Yan Dai
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

Review 6.  Regulation of SIRT1 by microRNAs.

Authors:  Sung-E Choi; Jongsook Kim Kemper
Journal:  Mol Cells       Date:  2013-11-06       Impact factor: 5.034

7.  Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesis.

Authors:  Arpita Roy; Miaojun Zhang; Yasser Saad; Pappachan E Kolattukudy
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-18       Impact factor: 4.249

Review 8.  Alcohol-induced protein hyperacetylation: mechanisms and consequences.

Authors:  Blythe D Shepard; Pamela L Tuma
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 9.  Epigenetics and the control of epithelial sodium channel expression in collecting duct.

Authors:  Dongyu Zhang; Zhi-yuan Yu; Pedro Cruz; Qun Kong; Shiyu Li; Bruce C Kone
Journal:  Kidney Int       Date:  2008-09-24       Impact factor: 10.612

10.  Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors.

Authors:  Annunziata Gloghini; Daniela Buglio; Noor M Khaskhely; Georgios Georgakis; Robert Z Orlowski; Sattva S Neelapu; Antonino Carbone; Anas Younes
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.